Insider Activity of Valantine Hannah
According to the SEC Form 4 filings, Valantine Hannah, being in a position of
- director at BridgeBio Pharma, Inc.,оver the last 12 months, has bought 0 shares, and sold 64643 shares for $4.37M,over all time since 2021-12-28, has bought 4090 shares for $54,976, and sold 98177 shares for $5.58M.
Biography of Valantine Hannah
No biography is available at this moment.